KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Precigen (PGEN) EBITDA Margin: 2012-2025

Historic EBITDA Margin for Precigen (PGEN) over the last 14 years, with Sep 2025 value amounting to -1,180.05%.

  • Precigen's EBITDA Margin rose 105101.00% to -1,180.05% in Q3 2025 from the same period last year, while for Sep 2025 it was -1,860.15%, marking a year-over-year increase of 169112.00%. This contributed to the annual value of -3,440.23% for FY2024, which is 183769.00% down from last year.
  • Precigen's EBITDA Margin amounted to -1,180.05% in Q3 2025, which was up 68.20% from -3,710.75% recorded in Q2 2025.
  • Over the past 5 years, Precigen's EBITDA Margin peaked at -45.53% during Q3 2022, and registered a low of -8,485.50% during Q2 2024.
  • Moreover, its 3-year median value for EBITDA Margin was -2,231.06% (2024), whereas its average is -2,613.60%.
  • Its EBITDA Margin has fluctuated over the past 5 years, first plummeted by 729,025bps in 2024, then skyrocketed by 477,475bps in 2025.
  • Precigen's EBITDA Margin (Quarterly) stood at -593.70% in 2021, then tumbled by 64,266bps to -1,236.36% in 2022, then crashed by 155,061bps to -2,786.97% in 2023, then spiked by 39,067bps to -2,396.30% in 2024, then skyrocketed by 105,101bps to -1,180.05% in 2025.
  • Its EBITDA Margin stands at -1,180.05% for Q3 2025, versus -3,710.75% for Q2 2025 and -1,685.01% for Q1 2025.